Viatris
General
Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit
Private equity firm KKR & Co. is exploring options for a potential sale of its 53.8% controlling stake in Mumbai-based ......
Healthcare
Matrix Labs founder Nimmagadda Prasad's firm buys Viatris' India API business
Viatris Inc., the result of the merger between Mylan NV and Pfizer Inc.’s Upjohn unit in 2020, has sold two ......
Healthcare
Biocon Biologics appoints new MD, CEO
Biocon Biologics on Monday said it has appointed Shreehas Tambe as managing director and chief executive officer of the company. ......
Healthcare
Biocon concludes Viatris' $3 bn acquisition
Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, on Tuesday announced completion of acquisition of Viatris' global biosimilars business for ......
Healthcare
Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June
Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......
Healthcare
India's Biocon in talks with Mylan to merge biosimilar businesses - Moneycontrol
Indian drugmaker Biocon Ltd is in talks with generic drugmaker Mylan for a merger of their biosimilar businesses, financial news ......